The analysis, which considers different scenarios of how the pandemic will play out, projects costs in the national commercial market to range from $34 billion to $251 billion. Cost includes testing, treatment and COVID-19 care.
When compared to premium, the analysis predicts COVID-19 costs could range from about 2 percent of premium to more than 21 percent of premium.
Health insurers are in the process of setting their rates for 2021. With these costs in mind, health insurers may raise their premiums between 4 percent and more than 40 percent to recoup 2020 losses, according to the analysis.
More articles on payers:
16 insurers waiving costs for COVID-19 treatment
Trump administration to use hospital stimulus funds to pay for uninsured COVID-19 treatment
Humana to expedite claim processing, suspend more prior authorization rules
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
